BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
First Financial Corporation Common Stock
THFF
$691M
| $102K | ﹤0.01% |
3,264
+2,595
| +388% | +$81.5K |
|
2352
Fortis
FTS
$24.9B
| $102K | ﹤0.01% |
2,500
| – | – |
|
|
COWN
2353
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $102K | ﹤0.01% |
6,277
+5,283
| +531% | +$86K |
|
2354
Tredegar Corp
TG
$279M
| $102K | ﹤0.01% |
6,854
+4,624
| +207% | +$68.8K |
|
2355
Johnson Outdoors
JOUT
$422M
| $102K | ﹤0.01% |
1,243
+1,023
| +465% | +$83.8K |
|
|
WIFI
2356
DELISTED
Boingo Wireless, Inc.
WIFI
| $102K | ﹤0.01% |
9,961
+8,375
| +528% | +$85.4K |
|
2357
American Vanguard Corp
AVD
$160M
| $101K | ﹤0.01% |
7,714
+5,046
| +189% | +$66.3K |
|
2358
The RMR Group
RMR
$288M
| $101K | ﹤0.01% |
3,688
+2,710
| +277% | +$74.4K |
|
2359
Omega Flex
OFLX
$340M
| $101K | ﹤0.01% |
646
+546
| +546% | +$85.6K |
|
|
AERI
2360
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $101K | ﹤0.01% |
8,601
+6,211
| +260% | +$73.1K |
|
2361
Rigel Pharmaceuticals
RIGL
$681M
| $101K | ﹤0.01% |
4,218
+3,630
| +617% | +$87.1K |
|
2362
Community Trust Bancorp
CTBI
$1.03B
| $101K | ﹤0.01% |
3,581
+3,011
| +528% | +$85.1K |
|
2363
Prothena Corp
PRTA
$442M
| $100K | ﹤0.01% |
10,022
+4,450
| +80% | +$44.5K |
|
|
FSP
2364
Franklin Street Properties
FSP
$174M
| $100K | ﹤0.01% |
27,319
+13,394
| +96% | +$49K |
|
|
RESI
2365
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $99.8K | ﹤0.01% |
11,421
+6,433
| +129% | +$56.2K |
|
2366
Horizon Bancorp
HBNC
$833M
| $99.8K | ﹤0.01% |
9,891
+8,330
| +534% | +$84.1K |
|
|
NGM
2367
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $99.7K | ﹤0.01% |
6,266
+5,138
| +455% | +$81.7K |
|
2368
Diamond Hill
DHIL
$387M
| $99.5K | ﹤0.01% |
788
+597
| +313% | +$75.4K |
|
|
MORF
2369
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $99.5K | ﹤0.01% |
3,638
+2,457
| +208% | +$67.2K |
|
|
OPRA
2370
Opera Ltd
OPRA
$1.76B
| $99K | ﹤0.01% |
+10,124
| New | +$99K |
|
|
GTS
2371
DELISTED
Triple-S Management Corporation
GTS
| $98.9K | ﹤0.01% |
5,534
+4,393
| +385% | +$78.5K |
|
2372
iShares MSCI Thailand ETF
THD
$235M
| $98.6K | ﹤0.01% |
1,572
-43,535
| -97% | -$2.73M |
|
2373
MannKind Corp
MNKD
$1.71B
| $98.3K | ﹤0.01% |
52,296
+42,082
| +412% | +$79.1K |
|
2374
Universal Insurance Holdings
UVE
$719M
| $98.2K | ﹤0.01% |
7,093
+5,226
| +280% | +$72.3K |
|
2375
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $97.9K | ﹤0.01% |
6,390
+5,003
| +361% | +$76.6K |
|